Modular Medical Shares Trading Higher, Co Hosted Conference Call Today At 8:30 ET To Discuss FDA Clearance Of The MODD1 Insulin Pump, As Well As Next Steps And Milestones
Portfolio Pulse from Benzinga Newsdesk
Modular Medical, Inc. (NASDAQ:MODD) announced FDA clearance for its MODD1 insulin pump and will host a conference call to discuss next steps and milestones.
September 05, 2024 | 3:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Modular Medical has received FDA clearance for its MODD1 insulin pump, a significant regulatory milestone. The company will discuss future plans in a conference call.
FDA clearance is a critical regulatory milestone that can positively impact Modular Medical's stock price. The clearance allows the company to proceed with its product launch, potentially increasing market share and revenues. The conference call will provide further insights into the company's strategic plans, which could influence investor sentiment.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100